Pharmacovigilance

Navigating Shifting Requirements and an Explosion of Data in Pharmacovigilance

Sally Amanuel

PrimeVigilance

Pediatric Clinical Trials

Pediatric Clinical Trials: Considerations for Enrollment and Retention

Susan McCune, M.D.; Anusha Streubel, M.D.; Elizabeth Donahue

Digital Pathology

Advancing Disease Research and Drug Development on an Enterprise Pathology Software Platform

Nathan Buchbinder

Proscia

Recombinant Antibody

Recombinant Antibody Technology is Crucial to Past and Future Success in Biopharma

Suranjana Sen, Ph.D.

Sino Biological

Sustainable Clinical Trials

Fostering a Sustainable Future in Clinical Trials through Decentralized Trial Models

Michael J. Cohen

PPD, part of Thermo Fisher Scientific

Decentralized Clinical Trials

Innovating DCTs Through Application and Cross-Functional Delivery

Jennifer Crager; Sandra Orset, Ph.D.

PPD, part of Thermo Fisher Scientific

Preclinical Data

Transforming Drug Development with Frictionless Access to Real-Time Preclinical Data

Mark Mintz; Kristen M. Eisenhauer

Charles River Laboratories

Cloud-Based Platform

Charles River Launches Apollo™, an Industry-Leading, Secure, Cloud-Based Platform for Real-Time Toxicology Study Data

Charles River Laboratories

Artificial Intelligence in Antibody Design

Accelerated and Cost-Effective Antibody Design Using Artificial Intelligence

Sumana Sundaramurthy, Ph.D.

Sino Biological

Recombinant Proteins

The Expanding Role for Recombinant Proteins in Research

Rob Burgess, Ph.D.

Sino Biological

Asia-Pacific DCTs

Interest in Decentralized Trials Rising in Asia-Pacific

Ryan Jiang; Shiho Yamanaka; Wai Hong Yuen; Eve Kamau MSc, RN

PPD, part of Thermo Fisher Scientific

Decentralized Clinical Trial Design

Reducing the Challenges Sites Face when Implementing Decentralized Trials

Kamilla Posselt

PPD, part of Thermo Fisher Scientific

European DCTs

Exploring Challenges and Considerations for Operationalizing DCTs in the European Union

Kamilla Posselt

PPD, part of Thermo Fisher Scientific

CRO

Crafting a Successful Partnership with a Contract Research Organization

Aptinyx

Gene Therapy Analytics

Overcoming Analytical Challenges for Gene Therapies

Jennifer Chadwick, Ph.D.

ProtaGene

M&A

Ginkgo Bioworks Signs Definitive Agreement to Acquire FGen AG, a Leading Bioengineering Company and Its Proprietary Ultra-High-Throughput Screening Platform

Ginkgo Bioworks

Rare Disease Clinical Trials

Rare Disease Patients Benefit from Clinical Trial Flexibility

Tim Rich; Meredith McCumbee; Francis Jones, Ph.D.

PPD, part of Thermo Fisher Scientific

Business Leadership

Former Surgeon General Jerome Adams Announced as Chairman of the Board of Total Diversity Clinical Trial Management

TOTAL Diversity Clinical Trial Management

Investment

Focusing on the Potential of Midsized Pharma Service Organizations

Edgewater Capital Partners

CRO

Accelerating Large Molecule Drug Development

Haematologic Technologies